Skip to main content
SpringerLink
Log in

Traitements médicamenteux de la migraine de l’enfant et de l’adolescent

  • Chapter
Migraine, céphalées de l’enfant et de l’adolescent

  • 516 Accesses

Résumé

Les médicaments de la migraine de l’enfant ont donné lieu depuis une dizaine d’années à plusieurs études. Ces données nous permettent de donner des recommandations claires et précises pour le traitement de crise contrairement au traitement de fond où aucun consensus n’apparaît.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Fernandes R, Ferreira JJ, Sampaio C (2008). The placebo response in studies of acute migraine. J Pediatr 152(4): 527–33, 533

    Article  PubMed  Google Scholar 

  2. Lewis DW, Winner P, Wasiewski W (2005). The placebo responder rate in children and adolescents. Headache 45(3): 232–9

    Article  PubMed  Google Scholar 

  3. Headache classification subcommittee of the International Headache Society (2004). The international classification of headache disorders 2nd edition. Cephalalgia 24. Suppl 1

    Google Scholar 

  4. AFSSAPS (2009). Prise en charge médicamenteuse de la douleur aiguë et chronique chez l’enfant. Recommandations de bonne pratique (RBP)

    Google Scholar 

  5. Ho TW, Pearlman E, Lewis D et al. (2012). Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia 32(10): 750–65

    Article  PubMed  Google Scholar 

  6. Hewitt DJ, Pearlman E, Hamalainen M et al. (2012). Long-Term Open-Label Safety Study of Rizatriptan Acute Treatment in Pediatric Migraineurs. Headache 18(10) 4610

    Google Scholar 

  7. McDonald SA, Hershey AD, Pearlman E et al. (2011). Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents. Headache 51(9): 1374–87

    Article  PubMed  Google Scholar 

  8. Eiland LS, Jenkins LS, Durham SH (2007). Pediatric migraine: pharmacologic agents for prophylaxis. Ann Pharmacother 41(7): 1181–90

    Article  CAS  PubMed  Google Scholar 

  9. Lewis DW, Diamond S, Scott D, Jones V (2004). Prophylactic treatment of pediatric migraine. Headache 44 (3, 230–237

    Article  PubMed  Google Scholar 

  10. Lewis D, Ashwal S, Hershey A et al. (2004). Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 28; 63(12): 2215–24

    Article  Google Scholar 

  11. Damen L, Bruijn J, Verhagen AP et al. (2006). Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials. Cephalalgia 26(5): 497–505

    Article  CAS  PubMed  Google Scholar 

  12. Sorge F, De SR, Marano E et al. (1988). Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 8(1): 1–6

    Article  CAS  PubMed  Google Scholar 

  13. Sorge F, Marano E (1985). Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia 5. Suppl 2: 145–8

    PubMed  Google Scholar 

  14. ANAES (2003). Prise en charge diagnostique et thérapeutique de la migraine chez l’adulte et l’enfant. Aspects cliniques et économiques. Recommandations pour la pratique clinique

    Google Scholar 

  15. Winner P, Pearlman EM, Linder SL et al. (2005). Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 45(10): 1304–12

    Article  PubMed  Google Scholar 

  16. MacLennan SC, Wade FM, Forrest KM et al. (2008). High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol 23(11): 1300–4

    Article  PubMed  Google Scholar 

  17. Bruijn J, Duivenvoorden H, Passchier J et al. (2010). Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial. Cephalalgia 30(12): 1426–34

    Article  PubMed  Google Scholar 

  18. Abu-Arafeh I (2012). Flunarizine for the prevention of migraine — a new look at an old drug. Dev Med Child Neurol 54(3): 204–5

    Article  PubMed  Google Scholar 

  19. Lewis D, Winner P, Saper J et al. (2009). Randomized, double-blind, placebo-controlled study to evaluate the Efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 123(3): 924–34

    Article  PubMed  Google Scholar 

  20. Tepper SJ (2012). Opioids should not be used in migraine. Headache 52. Suppl 1: 30–4

    Article  PubMed  Google Scholar 

  21. Trautmann E, Lackschewitz H, Kroner-Herwig B (2006). Psychological treatment of recurrent headache in children and adolescents: a meta-analysis. Cephalalgia 26(12): 1411–26

    Article  CAS  PubMed  Google Scholar 

  22. Lewis DW, Diamond S, Scott D, Jones V (2004). Prophylactic treatment of pediatric migraine. Headache 44(3): 230–7

    Article  PubMed  Google Scholar 

  23. Silver S, Gano D, Gerretsen P (2007). Acute treatment of paediatric migraine: a meta-analysis of Efficacy. J Paediatr Child Health 14

    Google Scholar 

  24. Damen L, Bruijn JK, Verhagen AP et al. (2005). Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics 116(2): e295–e302

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre de référence de la migraine de l’enfant et de l’adolescent - Centre de la douleur de l’enfant et de l’adolescent, Hôpital Armand-Trousseau (AP-HP), 26, avenue du Docteur-Arnold-Netter, 75571, Paris Cedex 12, France

    D. Annequin

Authors
  1. D. Annequin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Annequin .

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Paris

About this chapter

Cite this chapter

Annequin, D. (2014). Traitements médicamenteux de la migraine de l’enfant et de l’adolescent. In: Migraine, céphalées de l’enfant et de l’adolescent. Springer, Paris. https://doi.org/10.1007/978-2-8178-0235-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0235-0_6

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0234-3

  • Online ISBN: 978-2-8178-0235-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation